Articles tagged with Cancer
Moderate and vigorous aerobic physical activity combined with muscle-strengthening activity may lower mortality risk. Higher levels of moderate and vigorous aerobic activity are associated with lower cancer and all-cause mortality rates.
Researchers analyzed data from 230,000 individuals with second primary cancers, revealing higher mortality rates among Black and Hispanic populations compared to whites. The study highlights the need for targeted research on survival disparities in multiple primary cancer survivors.
Researchers highlight the need for effective treatment strategies for adenoid cystic carcinoma (ACC) of the head and neck, which is a highly malignant tumor with variable localizations. Proton therapy shows decisive advantages in long-term survival rates for ACC.
Researchers successfully deployed CAR-T therapy in a mouse model of ovarian cancer, demonstrating strong anti-tumor effects even at late stages. The treatment was highly effective, shrinking or eliminating tumors after just one dose and continuing to work for months without major side effects.
A study by Harvard T.H. Chan School of Public Health found that chronic exposure to fine particulate air pollutants (PM2.5) and nitrogen dioxide (NO2) may increase non-lung cancer risk in older adults, with significant associations with colorectal and prostate cancers.
Researchers discovered a pair of genes whose expression by immune cells in tumors is linked to patient outcomes and controls human cancers. The study identified a gene expression ratio that predicts tumor behavior and potential therapy targets, offering new insights into cancer treatment.
Human cells have been found to synchronize their movements in unison, similar to grandfather clocks, allowing them to work more efficiently and combat diseases. This new understanding can pave the way for developing biochemical tools to prevent serious diseases like cancer and diabetes.
Researchers propose disease-oriented dosing of rapamycin to delay age-related diseases and increase lifespan. By decelerating early development of these diseases, rapamycin may help individuals live longer.
Researchers found that individuals exposed to wildfires within a year of lung cancer surgery had significantly lower overall survival rates compared to those not exposed. The closer the exposure occurred to the surgery, the worse the survival rate, with patients exposed 3-6 months after surgery facing a 48% decrease in survival chances.
A new study shows that estrogen receptor (ER) expression in ductal carcinoma in situ (DCIS) is multi-clonal, meaning it varies across different cells. This finding has significant clinical implications, as it may help avoid overtreatment and undertreatment in DCIS patients.
A team led by CHLA's Dr. Jesse Berry is conducting an international liquid biopsy retinoblastoma study to investigate the use of liquid biopsies for diagnosis and disease severity determination. The study will provide valuable genetic and chromosomal information, enabling oncologists to diagnose retinoblastoma at a molecular level.
Researchers Yuesheng Zhang and his team aim to understand how mutated p53 proteins regain their cancer-fighting abilities through the manipulation of interactions with peptidase D (PEPD). The goal is to develop novel treatment strategies targeting PEPD to restore antitumor properties in various forms of cancer.
A recent study published in Immunity has found that ketone bodies, produced by the liver during fasting or low glucose levels, power immune cells and improve T cell function. This discovery may pave the way for personalized dietary recommendations to augment treatments for infection, cancer, and other diseases.
A breakthrough treatment targeting bone marrow cancer cells destroyed 90% of multiple myeloma cells in laboratory tests and 60% in human tissue samples. Researchers developed lipid-based nanoparticles containing RNA molecules that silence the CKAP5 gene, inhibiting cancer cell division.
Researchers found that just 4.5 minutes of vigorous activity per day can reduce the risk of some cancers by up to 32 percent. This type of physical activity, known as VILPA, involves short bursts of activity such as housework or power walking.
A study of 22,000 adults found that small amounts of vigorous intermittent lifestyle physical activity were associated with a lower incident cancer risk. This finding suggests that daily vigorous intermittent lifestyle physical activity may be a promising intervention for cancer prevention in populations unable or unmotivated to exercise.
Researchers have developed an innovative RNA-based strategy to activate dendritic cells, which play a key role in immune response. The approach, called CATCH, eradicated tumors and prevented their recurrence in mouse models of melanoma, suggesting its potential effectiveness against different cancer types.
A recent study found that increased skin cancer screening is not enough to address racial disparities in melanoma survival rates. Researchers suggest that educating physicians about presentation of melanoma in skin of color and making sure people have access to a dermatologist when they have a suspicious lesion could be more effective.
Research reveals that cancer screening awareness is low among people experiencing homelessness, making it difficult for them to receive timely treatment. The study's findings highlight the need for targeted prevention programs tailored to this underserved group's unique needs.
Researchers at UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh School of Medicine found that eliminating a key driver of cancer also hastened aging in mice. Despite accelerated aging, these mice lived up to 20% longer than normal mice due to lower cancer rates.
Researchers found that CD4+ T cells initiate fat wasting, while CD8+ T cells induce muscle wasting, which surprisingly helps the mice fight infection and survive. The study sheds light on the complex relationship between immune cells and wasting responses.
A new diet score reveals that people who follow a more sustainable diet are 25% less likely to die during a 30-year follow-up period. Plant-based foods are associated with lower risks of chronic diseases and reduced environmental impacts.
Researchers at MIT have developed a novel sensor that can detect immune molecule CXCL12, which plays a crucial role in several human diseases including cancer. The device uses receptor proteins found in cell membranes, making it a potential tool for early screening of hard-to-diagnose cancers.
Researchers from Korea University Medicine have discovered a potential therapeutic target for overcoming cisplatin resistance and neuropathic pain in cervical cancer. By inhibiting TRPV1, they found that resistant tumors became vulnerable to cisplatin, improving the outlook for patients.
Researchers discovered GDF-15 blocks LFA-1 dependent T cell recruitment into the tumor microenvironment, impairing immune responses to anti-PD-1 treatment. Visugromab improved T cell infiltration and increased tumor clearance with a synergistic effect
UCSB researchers develop platform to interpret cellular 'stress memory landscape', predicting future reaction to stressors. The study opens window into various cellular stress-related conditions, including aging, cancer and neurodegenerative diseases.
Researchers propose targeting non-canonical HH/GLI signaling to improve response rate and durability of therapeutic effects exerted by SMO inhibition in melanoma. The findings suggest that combined targeting of hedgehog signaling and BRD4 could provide a novel therapeutic option against melanoma.
Scientists have teamed up to improve drug delivery by designing more effective lipid nanoparticles. Their latest study documents how high-throughput workflows can produce and characterize LNPs at record speed, with neatly ordered structures leading to better silencing of faulty genes in human neurons.
A team of UVA Health experts warns that surgeon-scientists are struggling to obtain research funding, which could lead to a decline in innovations for patients. The researchers found that internal medicine trainees are six times more likely to secure R01 grants and career development awards.
Researchers at Tokyo Institute of Technology developed a novel boron agent that selectively accumulates in brain tumor cells, exhibits enhanced blood retention, and can be administered at low doses. The agent, PBC-IP, shows promising results in preclinical studies, highlighting its potential for radiotherapy in treating glioblastoma.
A new study by researchers at Dartmouth Cancer Center shows that a combination of estrogen and PARP inhibitors can effectively treat advanced ER+ breast cancer by damaging cancer cells and preventing DNA repair. The treatment strategy has been shown to be effective regardless of BRCA1 or BRCA2 genetic mutations.
A new study by Rice University bioscientists reveals how plant cells collaborate to fuel growth, shedding light on corresponding mechanisms in human cells. The findings focus on the role of enzyme MIEL1 and its human counterpart PIRH2 in breaking down protein coatings on lipid droplets.
Professor Coppedè's appointment aims to enhance the journal's focus on cutting-edge genomics research, covering topics like genome sequencing and functional genomics. He will lead Current Genomics to greater success by staying at the forefront of genomics discoveries and advancements.
A study found that high tumor monocyte content is linked to improved outcomes in esophageal cancer patients treated with a combination of chemotherapy and immunotherapy. The degree of tumor mutational burden also predicts survival outcomes, suggesting a potential biomarker for selecting patients likely to benefit from immunochemotherapy.
Researchers at Nanyang Technological University discover ponatinib, an existing cancer drug, can block key steps in alternative lengthening of telomeres (ALT) mechanism. This could lead to new treatment options for ALT cancers, which currently lack targeted therapies.
Researchers at Paul Scherrer Institute have developed a beamline modification called momentum cooling to increase the transmission of proton beams, allowing for shorter treatment times. This breakthrough could enable faster treatments while maintaining accuracy and sparing healthy tissue, with potential benefits including reduced costs...
Researchers found that cigarette smoke and HPV interact to heighten the risk of head and neck cancer by increasing oxidative stress and DNA damage. The study's results pave the way for novel strategies in prevention and treatment.
Scientists have developed a method to engineer tubulins with precise post-translational modifications, revealing a new interplay between polyglutamylation and detyrosination. This breakthrough uncovers the tubulin code's connection to microtubule function and its regulation in cells.
Researchers at UC San Diego found a novel combination of KRAS and ERBB drug inhibitors outperformed treatments in human and mouse models of pancreatic cancer. The combination reduced drug resistance and increased survival rates.
A randomized trial will be conducted to test whether sticking with the initial medication or switching to a different one increases quitting success. The study aims to provide guidance for clinicians on handling relapses and may explore the effectiveness of e-cigarettes as an alternative to traditional cigarettes.
A Michigan State University researcher has received a $3.2 million grant to develop tools for cancer survivors to manage symptoms and improve their well-being while taking oral anti-cancer medications. The project aims to provide scalable symptom monitoring and self-management strategies to reduce costs and emergency department visits.
Researchers have developed a new technique to generically treat several kinds of cancer, showing tumors grew almost three times less and survival rates reached 100% after just one injection. The method targets cancer cells with alpha radiation, sparing healthy tissue.
The Biden-Harris Administration has launched a $50 million initiative to improve cancer outcomes in persistent poverty areas. The Persistent Poverty Initiative aims to build research capacity, foster cancer prevention research, and promote community-based programs to address the cumulative effects of poverty on cancer outcomes.
The study investigates the effects of DPDT on human colon cancer HCT116 cells and non-tumorigenic MRC5 fibroblasts. The results show that DPDT preferentially targets HCT116 cells, inducing apoptosis and G2/M cell cycle arrest, likely through DNA topoisomerase I poisoning.
Researchers analyzed data on 34,789 endometrial cancer cases from Florida and the French Caribbean, finding that Caribbean Black women had the lowest rates for both subtypes. Non-endometrioid types were most common among US Black women, with rates increasing yearly for all groups.
A nationwide study of nearly two million women found that those with PCOS who have undergone menopause are more than twice as likely to be diagnosed with ovarian cancer. The risk was also significantly higher for a type of ovarian tumor known as serous borderline, which can lead to cancer later on.
Researchers have discovered that gene editing technologies may introduce unintended mutations and damage to DNA in early human embryos. The study found that most cells repair breaks in the DNA using non-homologous end joining, which can lead to additional genetic abnormalities.
A pioneering device captures single proteins stochastically, detecting them digitally at high concentrations. This breakthrough could lay the foundation for personalized disease prevention and treatment.
Researchers developed a platform called Orion that bridges parallel worlds of microscopic analysis and multiplexed tissue imaging. The platform enables the integration of information from each source into a comprehensive view across the entire slide, predicting patient prognosis and tumor behavior.
Children with parental cancer history face higher rates of unmet economic needs, including food security, housing affordability and transportation access. The study highlights the need for strategies to identify and support these vulnerable children.
Researchers have identified anti-malarial properties in cancer drugs, offering a potential solution to the growing crisis of drug-resistant malaria. The study found that certain protein kinase inhibitors exhibited strong anti-malarial effects, highlighting a new approach to accelerating drug discovery.
Rice University engineers developed a low-cost, point-of-care DNA test for HPV infections that can be used to screen for cervical cancer. The test, which requires just two pieces of equipment and delivers results in 45 minutes, has the potential to make cervical cancer screening more accessible in low- and middle-income countries.
Rensselaer Polytechnic Institute researcher Scott Forth is investigating the mechanical code underlying mitosis to combat cancer. His lab aims to determine how chromosomes are segregated during cell division, with potential insights into new diagnostics and treatments.
Researchers developed tiny nano-sized pores that can detect specific proteins in complex biological fluids, such as blood. The breakthrough enables fast and accurate disease diagnosis, potentially leading to earlier interventions and improved treatment outcomes.
Researchers at UC San Diego have discovered that shattered DNA fragments are tethered together during cell division, allowing them to be reassembled in a different order. Destroying the tether may help prevent cancerous mutations and is now being explored as a therapeutic target.
A study by Martin-Luther-University Halle-Wittenberg found a link between high levels of IGF2BP2 and faster-growing bowel cancer tumours with chemotherapy resistance. The protein's role in cell growth and metabolism may lead to the development of new diagnostic procedures and therapeutic strategies.
Researchers at City of Hope have developed a universal donor stem cell therapy that can treat degenerative brain diseases such as Canavan disease and Alzheimer's. The therapy, which uses an 'off-the-shelf' approach, has shown promising results in preclinical studies, reducing toxic accumulation of metabolites and improving motor function.
Researchers found that morphine interacts with toll-like receptor 4 to contribute to increased bone loss and pain. Blocking TLR4 prevents these effects, suggesting a new target for reducing opioid side effects.
Research suggests that the Bhopal gas disaster had long-term intergenerational effects on health and education. Men exposed in utero to toxic gas had a higher risk of disabilities and cancers, while those born later had reduced educational attainment. The sex ratio of births also changed among children born near the incident site.
Researchers discovered that components of heat-marred DNA can be absorbed during digestion and incorporated into the DNA of consumers, potentially triggering genetic mutations. This finding has important implications for dietary choices and public health, highlighting the need to reassess cooking methods.